| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 12/13/2001 | WO2001041701A3 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 12/13/2001 | WO2001032139A3 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 12/13/2001 | WO2001019399A3 Method of potentiating chemotherapy and treating solid tumors |
| 12/13/2001 | US20010051628 Methods to modulate the resistance of cells to apoptosis mediated by mutant epidermal growth factor receptors |
| 12/13/2001 | US20010051595 Injection into blood |
| 12/13/2001 | US20010051160 Satisfy composition and method of weight control |
| 12/13/2001 | US20010051133 Purity carbonated distillated water |
| 12/13/2001 | US20010050215 Process for producing sterile water for injection from potable water |
| 12/13/2001 | CA2408609A1 Compositions, kits, and methods for promoting defined health benefits |
| 12/12/2001 | EP1162176A1 Electrolyzed water of anode side and process for production thereof |
| 12/12/2001 | EP1161280A1 Use of an integrin antagonist and a chemotherapeutic agent in the treatment of neoplasia |
| 12/12/2001 | EP1161265A1 Method for the identification and removal of nits from hair |
| 12/12/2001 | EP1161248A1 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 12/12/2001 | CN1326338A Process for preparing oral calcium compositions |
| 12/12/2001 | CN1325708A Multipurpose anticancer ointment |
| 12/12/2001 | CN1325691A Antagesic Chinese medicine and its preparing process and usage |
| 12/12/2001 | CN1325690A Chinese medicine for treating cancers |
| 12/12/2001 | CN1325680A Lotion for cleaning nasal and nasopharyngeal cavities |
| 12/12/2001 | CN1075947C Compound hemorrhbids necrotized oil for treating anal and intes tinal disease and its preparation method |
| 12/11/2001 | US6329432 Mesozeaxanthin formulations for treatment of retinal disorders |
| 12/11/2001 | US6329394 Medical use for tachykinin antagonists |
| 12/11/2001 | US6329355 Method for inhibiting the growth of cancers |
| 12/11/2001 | US6328997 Magnesium bicarbonate |
| 12/11/2001 | US6328947 Hydrolyzing metal halide in the presence of organic solvent to obtain fine particles of metal oxide |
| 12/11/2001 | US6328708 Device for controlled anaesthesia, analgesia and /or sedation |
| 12/06/2001 | WO2001091772A2 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 12/06/2001 | WO2001091770A2 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 12/06/2001 | WO2001091768A2 Compositions for treating brain disorders and enhancing brain function, containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 12/06/2001 | WO2001091765A2 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 12/06/2001 | WO2001091762A1 Zinc-supplementary compositions for oral administration |
| 12/06/2001 | WO2001091741A2 Compositions containing hexitol and an antiproliferative agent |
| 12/06/2001 | WO2001091740A2 Compositions containing naphthaquinone and an antiproliferative agent |
| 12/06/2001 | WO2001091734A2 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |
| 12/06/2001 | WO2001034130A9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 12/06/2001 | WO2001022922A3 Engineering antibodies that bind irreversibly |
| 12/06/2001 | WO2001000193A3 Zinc ionophores as anti-apoptotic agents |
| 12/06/2001 | US20010049395 Method of induction of cell differentiation of malignant cells such leukemia |
| 12/06/2001 | US20010049364 Prevention of cancer |
| 12/06/2001 | US20010048951 Reduced concentration of carbon dioxide |
| 12/06/2001 | US20010048948 Intestine health; immunology; mixture containing whey |
| 12/06/2001 | US20010048915 Decreased endogenous nitric oxide activation |
| 12/06/2001 | CA2410900A1 Compositions and methods for treating eye discomfort |
| 12/06/2001 | CA2380367A1 Compositions for providing zinc through oral administration |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159941A2 Formulations for use in enzyme-orthokeratology |
| 12/05/2001 | EP1158992A1 Use of xenon for treating neurointoxications |
| 12/05/2001 | EP1158972A1 Treatment of hypertension with compounds that inhibit the destruction of enkephalins or endorphins |
| 12/05/2001 | EP1158859A1 Iodine preparation compositon |
| 12/05/2001 | EP0855912B1 Nitrogen monoxide composition for use as a drug |
| 12/05/2001 | EP0850204B1 Photocatalytic coating substrate |
| 12/05/2001 | EP0817639B1 Pharmaceutical composition containing selected lanthanum carbonate hydrates |
| 12/05/2001 | EP0786985B1 Method and composition for treatment of abnormal conditions of the epithelium of bodily orifices |
| 12/05/2001 | CN1325305A Method of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| 12/05/2001 | CN1325291A Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 12/05/2001 | CN1325277A Composition comprising a viscosity modulating polymer material and its use |
| 12/05/2001 | CN1324629A Gastropathy treating medicine and its prepn. |
| 12/05/2001 | CN1324607A Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt |
| 12/05/2001 | CN1075737C Method for the provocation of air passage narrowing and/or the induction of sputum |
| 12/05/2001 | CN1075731C Medicine for treating nasal polyp |
| 12/05/2001 | CN1075730C Wind-dispelling meridian passage-dredging and pus-drawing out medicinal powder |
| 12/04/2001 | US6326356 Antitumor agents |
| 12/04/2001 | US6326355 Method for the prevention and treatment of cachexia and anorexia |
| 12/04/2001 | US6326079 Substrate with a photocatalytic coating |
| 12/04/2001 | US6326034 From yeast or saltbush; regulate glucose and lipid metabolism, insulin; treatment of diabetes, cardiovascular diseases and hyperlipidemia; nontoxic |
| 11/29/2001 | WO2001089572A1 Systems and methods for topical treatment with nitric oxide |
| 11/29/2001 | WO2001089554A2 Treatment of acute coronary syndrome with glp-1 |
| 11/29/2001 | WO2001089542A2 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant |
| 11/29/2001 | WO2001089534A1 Use of metal compounds to treat gastrointestinal infections |
| 11/29/2001 | WO2001089533A2 Preparation for stabilizing the protective layer on the epithelium of the cornea or the alveoli |
| 11/29/2001 | WO2001089513A1 Use of citrate-containing dialysate for renal dialysis treatment |
| 11/29/2001 | WO2001089501A1 Polymerizable compositions and methods of use |
| 11/29/2001 | WO2001089478A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof |
| 11/29/2001 | WO2000061597A9 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
| 11/29/2001 | WO2000038666A3 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
| 11/29/2001 | US20010047035 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (NO) in specimens taken from the patient under controlled conditions |
| 11/29/2001 | US20010046980 Method of treatment of prostate cancer |
| 11/29/2001 | US20010046522 Herbal supplement for cognitive related impairment due to estrogen loss |
| 11/29/2001 | US20010046521 Administering an effective amount of cytotoxic chemical compound selected from nitrosourea, cyclophophamide, doxorubicin, 5-fluorouracil, cisplatin etc. in first treatment of cancer and squalamine in second treatment step |
| 11/29/2001 | US20010046520 A topical virucidal frmulation comprising an inorganic halide, an oxidising agent capable of generating hypohalite ions in aqueous solution, a sulfamic acid, a non-reducing organic acid, an inorganic phosphate, and excipients |
| 11/29/2001 | CA2409688A1 Method for improving the cell protection |
| 11/29/2001 | CA2407784A1 Treatment of acute coronary syndrome with glp-1 |
| 11/29/2001 | CA2403574A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof |
| 11/28/2001 | EP1157702A1 Compositions comprising DNA Damaging Agents and p53 |
| 11/28/2001 | EP1156828A1 Combination therapy for lymphoproliferative diseases |
| 11/28/2001 | EP1156811A2 Copper agonist that binds on the copper binding site of app and/or exerts an inhibiting effect on the release of amyloid a beta peptide |
| 11/28/2001 | EP1156810A2 Solution for injection for the treatment of arthroses |
| 11/28/2001 | EP1156789A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 11/28/2001 | EP1156777A1 Oral composition for inhibiting oral malodor |
| 11/28/2001 | CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 11/28/2001 | CN1323610A Proriasis treating Yinxieling capsule |
| 11/28/2001 | CN1323609A Weitai capsule for treating stomach disease |
| 11/28/2001 | CN1323606A Wound curing and swelling-eliminating tranditional Chinese medicine ointment and its pharmaceutical application |
| 11/28/2001 | CN1323596A Toxin-absorbing drying medicine |
| 11/28/2001 | CN1323584A External-use medicine liquid for diseases of eye, ear, nose and throat |
| 11/28/2001 | CN1075387C Antitumor agent potentiator comprising IL-6 antagonist |
| 11/28/2001 | CN1075383C Bone-setting and muscle-jointing-up medicine and prepn. method thereof |
| 11/27/2001 | US6323232 Combination therapy for osteoporosis |
| 11/27/2001 | US6323205 Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors |
| 11/27/2001 | US6323182 Concentrate for use in preparation of dialysis solution comprising gluconic acid and glucose in amounts such that upon dilution with aqueous solution in ratio of at least about 1:150, specified concentrations are obtained |